Didier Raoult: h-index, Total Citations, and Citation Map
Didier Raoult's h-index is 228 (2134 i10-index, 264,646+ total citations across 1,000+ publications) according to Google Scholar as of July 2026. Didier Raoult is affiliated with IHU Méditerranée Infection, Aix Marseille Université, AP-HM CHU Timone, Marseille, FRANCE.
Didier Raoult is a researcher affiliated with IHU Méditerranée Infection, Aix Marseille Université, AP-HM CHU Timone, Marseille, FRANCE, specializing in Rickettsia, Infectious Diseases, Viruses. Their work has been cited 264,646 times. This profile visualizes their global influence, spanning a global audience.
Didier Raoult's Citation Metrics
Bibliometric impact based on 1,000 indexed publications. Of these, 19 are original research articles — the rest are literature highlights, conference abstracts or theses.
- H-Index
- 228
- i10-Index
- 2134
- Total Citations
- 264,646
- Citing Countries
- 0
As of July 2026.
Didier Raoult has an h-index of 228 and 264,646 total citations across 1000 publications, with research cited by institutions in 0 countries.
Download Exports (PNG, CSV, Poster)
Free Viewing Didier Raoult's citation map is always free. Pay once to download poster, PNG, and CSV files for offline use or your visa packet.
Global Impact Map
Visualizing the geographic distribution of institutions that have cited your work.
Starting…
Pins will appear here as institutions are resolved — no need to refresh.
RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
20207,022
Top Citing Countries
Top Citing Institutions
No institution data available.
Citation trend (last 10 years)Click to expand
Citation Trend (Last 10 Years)
Related Guides
Learn how to use citation maps for your research and visa applications.
About Didier Raoult's research
Didier Raoult is a researcher in Rickettsia, Infectious Diseases and Viruses at IHU Méditerranée Infection, Aix Marseille Université, AP-HM CHU Timone, Marseille, FRANCE. Their work has been cited 264,646 times across 1,000 publications (h-index 228), according to Google Scholar.
Their most-cited work, “RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial” (2020), has accumulated 7,022 citations. Other influential works include “2018 publication — 6267 citations” (2018) with 6,267 citations and “Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota” (2015) with 3,971 citations.











